As we move through 2026, the biopharmaceutical industry is undergoing a radical technological transformation, moving far beyond simple recombinant proteins. The Cytokines Market Technology this year is defined by "Cis-targeting" and "Receptor-biasing" engineering. These sophisticated platforms allow scientists to modify the surface of cytokines so they only bind to specific immune...